NCT04359836 A Study to Explore the Role of Gut Flora in COVID-19 Infection
| NCT ID | NCT04359836 |
| Status | Recruiting |
| Phase | — |
| Sponsor | ProgenaBiome |
| Condition | Gut Microbiome |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2020-04-16 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2020-04-16 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study seeks to determine whether the virus which causes COVID-19, SARS-CoV-2, is shed in the stools of patients who are infected.
Eligibility Criteria
Inclusion Criteria: 1. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study 2. Male or female of 18 years of age or older 3. Diagnosis of COVID-19 infection by RT- PCR within 1 week of Screening Exclusion Criteria: 1. Refusal to sign informed consent form 2. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy. 3. Postoperative stoma, ostomy, or ileoanal pouch 4. Treatment with total parenteral nutrition
Contact & Investigator
Sabine Hazan, MD
PRINCIPAL INVESTIGATOR
ProgenaBiome
Frequently Asked Questions
Who can join the NCT04359836 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gut Microbiome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04359836 currently recruiting?
Yes, NCT04359836 is actively recruiting participants. Contact the research team at drsabinehazan@progenabiome.com for enrollment information.
Where is the NCT04359836 trial being conducted?
This trial is being conducted at Ventura, United States.
Who is sponsoring the NCT04359836 clinical trial?
NCT04359836 is sponsored by ProgenaBiome. The principal investigator is Sabine Hazan, MD at ProgenaBiome. The trial plans to enroll 250 participants.